» Articles » PMID: 22876184

IL-10 Suppression of NK/DC Crosstalk Leads to Poor Priming of MCMV-specific CD4 T Cells and Prolonged MCMV Persistence

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2012 Aug 10
PMID 22876184
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

IL-10 is an anti-inflammatory cytokine that regulates the extent of host immunity to infection by exerting suppressive effects on different cell types. Herpes viruses induce IL-10 to modulate the virus-host balance towards their own benefit, resulting in prolonged virus persistence. To define the cellular and molecular players involved in IL-10 modulation of herpes virus-specific immunity, we studied mouse cytomegalovirus (MCMV) infection. Here we demonstrate that IL-10 specifically curtails the MCMV-specific CD4 T cell response by suppressing the bidirectional crosstalk between NK cells and myeloid dendritic cells (DCs). In absence of IL-10, NK cells licensed DCs to effectively prime MCMV-specific CD4 T cells and we defined the pro-inflammatory cytokines IL-12, IFN-γ and TNF-α as well as NK cell activating receptors NKG2D and NCR-1 to regulate this bidirectional NK/DC interplay. Consequently, markedly enhanced priming of MCMV-specific CD4 T cells in Il10(-/-) mice led to faster control of lytic viral replication, but this came at the expense of TNF-α mediated immunopathology. Taken together, our data show that early induction of IL-10 during MCMV infection critically regulates the strength of the innate-adaptive immune cell crosstalk, thereby impacting beneficially on the ensuing virus-host balance for both the virus and the host.

Citing Articles

Mucosal T-cell responses to chronic viral infections: Implications for vaccine design.

Al-Talib M, Dimonte S, Humphreys I Cell Mol Immunol. 2024; 21(9):982-998.

PMID: 38459243 PMC: 11364786. DOI: 10.1038/s41423-024-01140-2.


Comprehensive Analysis of Soluble Mediator Profiles in Congenital CMV Infection Using an MCMV Model.

Karner D, Kvestak D, Lisnic B, Cokaric Brdovcak M, Juranic Lisnic V, Kucan Brlic P Viruses. 2024; 16(2).

PMID: 38399983 PMC: 10891658. DOI: 10.3390/v16020208.


Inhibitory IL-10-producing CD4 T cells are T-bet-dependent and facilitate cytomegalovirus persistence via coexpression of arginase-1.

Clement M, Ladell K, Miners K, Marsden M, Chapman L, Cardus Figueras A Elife. 2023; 12.

PMID: 37440306 PMC: 10344424. DOI: 10.7554/eLife.79165.


Natural killer cells in COVID-19: from infection, to vaccination and therapy.

Zafarani A, Razizadeh M, Pashangzadeh S, Amirzargar M, Taghavi-Farahabadi M, Mahmoudi M Future Virol. 2023; .

PMID: 36936055 PMC: 10013930. DOI: 10.2217/fvl-2022-0040.


Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections.

Mora-Bitria L, Asquith B Immunogenetics. 2023; 75(3):269-282.

PMID: 36719466 PMC: 9887252. DOI: 10.1007/s00251-023-01293-w.


References
1.
Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T . Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol. 2004; 173(10):6072-81. DOI: 10.4049/jimmunol.173.10.6072. View

2.
Saraiva M, OGarra A . The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010; 10(3):170-81. DOI: 10.1038/nri2711. View

3.
Wilson E, Brooks D . The role of IL-10 in regulating immunity to persistent viral infections. Curr Top Microbiol Immunol. 2010; 350:39-65. PMC: 3492216. DOI: 10.1007/82_2010_96. View

4.
Qian C, Jiang X, An H, Yu Y, Guo Z, Liu S . TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation. Blood. 2006; 108(7):2307-15. DOI: 10.1182/blood-2006-03-005595. View

5.
Cai G, Kastelein R, Hunter C . IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol. 1999; 29(9):2658-65. DOI: 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G. View